Faecal calprotectin but not C-Reactive Protein (CRP) or Crohn's Disease Activity Index (CDAI) may predict post-operative endoscopic recurrence of Crohn's Disease

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages

  Papamichael, Konstantinos ^a   Karatzas, Pantelis ^a   Mantzaris, Gerassimos J ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; FECAL CALPROTECTIN; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ACCURACY; COLONOSCOPY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; ERYTHROCYTE SEDIMENTATION RATE; HIGH RISK PATIENT; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LETTER; PHYSICAL EXAMINATION; POINT OF CARE TESTING; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAPID TEST; RECURRENT DISEASE; REFERENCE VALUE;

CROHN DISEASE; FECES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE;

EID: 84887618600     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.07.008     Document Type: Letter

References (5)

1. Lamb C.A.M., Mohiuddin K., Gicquel J., Neely D., Bergin F.G., Hanson J.M., et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009, 96:663-674.
2. Scarpa M., D'Inca R., Basso D., Ruffolo C., Polese L., Bertin E., et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease. Dis Colon Rectum Jun 2007, 50:861-869.
3. Lobatón T., López-García A., Rodríguez-Moranta F., Ruiz A., Rodríguez L., Guardiola J. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. J Crohns Colitis 2013, 10.1016/j.crohns.2013.05.005.
4. Papamichael K., Archavlis E., Kyriakos N., Kalantzis C., Drougas I., Konstantopoulos P., et al. Faecal calprotectin but not serum CRP predicts post-operative endoscopic recurrence of Crohn's disease. J Crohns Colitis 2012, 6(Suppl. 1):S169.
5. Papamichael K., Archavlis E., Lariou C., Mantzaris G.J. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. J Crohns Colitis 2012, 6:924-931.